China Longevity : Announcements and Notices - Update on Suspension of Trading

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA LONGEVITY GROUP COMPANY LIMITED

中國龍天集團有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1863) UPDATE ON SUSPENSION OF TRADING

This announcement is made by China Longevity Group Company Limited (the "Company") pursuant to Rule 13.09 and Rule 13.24A of the Rules Governing the Listing of Securities (the "Listing Rules") on The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the Inside Information Provisions (as defined under the Listing Rules) and Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Reference is made to the announcement of the Company dated 13 June 2014 (the "Announcement") in relation to the resumption conditions imposed by the Stock Exchange (the "Resumption Conditions") and the notice issued by the Stock Exchange to suspend all dealings in the shares of the Company pursuant to Rule 8(1) of the Securities and Futures (Stock Market Listing) Rules on 4 December 2014 (the "Rule 8(1) Notice").

PROGRESS OF FULFILLMENT OF THE RESUMPTION CONDITIONS

The board (the "Board") of directors (the "Directors") of the Company would like to update the shareholders of the Company (the "Shareholders") that it has been working closely with its legal advisers to fulfill the Resumption Conditions and has provided relevant information to the Stock Exchange with a view to address its regulatory concerns.

THE RULE 8(1) NOTICE

On 24 November 2014, the Company was informed by the Securities and Futures Commission (the "SFC") that it was concerned that materially false, incomplete or misleading information had been included in the Company's financial statements issued between 30 March 2012 and 15 September 2014 and that the related announcements issued by the Company are false or misleading by omission and that the market for the Company's shares was not properly informed.

Despite the Company's submissions and explanations made to the SFC, the SFC directed the Stock Exchange to suspend all dealings in the shares of the Company from 9:00 am on 4 December 2014.

With a view to address the regulatory concerns of the SFC, the Company engaged a firm of independent forensic accountants (the "Forensic Accountants") to carry out independent forensic accounting review of the relevant matter. Notwithstanding the above, the Company is advised by the Forensic Accountants that the necessary documentation could not be obtained from relevant third parties such as customers and suppliers of the Company and therefore, the Forensic Accountants are unable to reach a conclusion from their review of the matter at this stage.

The Company shall keep the Shareholders and the public informed of the progress of any relevant development by way of further announcement(s) as and when appropriate.

By Order of the Board

China Longevity Group Company Limited Lin Shengxiong

Chairman

Hong Kong, 18 September 2017

As of the date of this announcement, the Board of the Company comprises three Executive Directors, namely, Mr. Lin Shengxiong, Mr. Huang Wanneng and Mr. Jiang Shisheng; three Independent Non- Executive Directors, namely, Mr. Lau Chun Pong, Mr. Lu Jiayu and Ms. Jiang Ping.